ADVANCED MEDICAL SOLUTIONS GROUP PLC — Director's Dealing 2017

Apr 10, 2017

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1032C

Advanced Medical Solutions Grp PLC

10 April 2017

	10 April 2017

Advanced Medical Solutions Group plc

("AMS", the "Company" or the "Group")

Director/PDMR and PCA Shareholding

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and advanced wound care markets, announces that the Board, following a recommendation from the Remuneration Committee, has granted new share options to the following Directors and PDMRs under the Advanced Medical Solutions Long Term Incentive Plan (the 'LTIP') on 6 April 2017.  The vesting period of these options is subject to certain performance criteria over a three year period.

Director/PDMR	Options prior to grant	Options granted	Resultant holding
Chris Meredith Chief Executive Officer	968,436	109,571	1,078,007
Mary Tavener Chief Financial Officer	591,199	84,762	675,961
Simon Coates PDMR	91,864	17,891	109,755
Rose Guang PDMR	138,011	24,067	162,078
Eddie Johnson PDMR	120,364	23,775	144,139
Pieter van Hoof PDMR	121,505	23,428	144,933
Becky Walmsley PDMR	50,000	23,082	73,082
Jeff Willis PDMR	132,044	40,550	172,594

Advanced Medical Solutions Group plc also announces that on 6 April 2017, the Board, following a recommendation from the Remuneration Committee, granted new share options to the following Directors under the Advanced Medical Solutions Deferred Annual Bonus Plan (the '2014 DAB').

This award is in respect of the part of their bonus that the Directors and PDMRs are compulsorily required to defer for the 2016 financial year. These options vest at the end of three years.

Director/PDMR	Options prior to grant	Options granted	Resultant holding
Chris Meredith Chief Executive Officer	82,218	23,369	105,587
Mary Tavener Chief Financial Officer	57,870	15,065	72,935
Simon Coates PDMR	4,438	3,306	7,744
Rose Guang PDMR	12,586	4,612	17,198
Eddie Johnson PDMR	14,803	4,556	19,359
Pieter van Hoof PDMR	13,490	4,329	17,819
Becky Walmsley PDMR	1,067	4,114	5,181
Jeff Willis PDMR	17,996	5,535	23,531

The notification below, made in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Chris Meredith

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 109,571 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 23,369 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Mary Tavener

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 84,762 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 15,065 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Simon Coates

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 17,891 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 3,306 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Rose Guang

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 24,067 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 4,612 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Eddie Johnson

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 23,775 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 4,556 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Pieter van Hoof

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 23,428 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 4,329 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Becky Walmsley

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 23,082 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 4,114 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name: Jeff Willis

2.

Reason for the notification

a)

Position/status: Director/PDMR

b)

Initial notification/Amendment: Initial Notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:   Advanced Medical Solutions Group plc

b)

LEI: 213800HJP6OWOSZI1L74

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument: Ordinary Shares of 5p

Identification code: GB0004536594

b)

Nature of the transactions:

·        Grant of 40,550 options under the Advanced Medical Solutions Long Term Incentive Plan on 6 April 2017

·        Grant of 5,535 options under the Advanced Medical Solutions Deferred Annual Bonus Plan on 6 April 2017

c)

Price(s) and volume(s):

Sale of shares:

Price(s)	Volume(s)
n/a	n/a

d)

Aggregated information: (Relates to those shares sold only)

Aggregated volume: n/a

Aggregated price: n/a

e)

Date of the transaction: 06/04/2017

f)

Place of the transaction: London Stock Exchange, AIM Market (XLON)

- End -

For further information, please visit www.admedsol.com or contact:

Advanced Medical Solutions Group plc	Tel: +44 (0) 1606 545508
Chris Meredith, Chief Executive Officer Mary Tavener, Chief Financial Officer
Consilium Strategic Communications	Tel: +44 (0) 20 3709 5700
Mary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys	AMS@consilium-comms.com
Investec Bank PLC (NOMAD & Broker)	Tel: +44 (0) 20 7597 5970
Daniel Adams / Patrick Robb

About Advanced Medical Solutions Group plc - see www.admedsol.com

AMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical and advanced wound care markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of wound care products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it sells under white label as well as its own brand ActivHeal®, and surgical tissue adhesives, sutures and haemostats, which markets under its own brands; LiquiBand® and RESORBA®.

AMS's products, manufactured out of two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic, are sold in more than 70 countries via a network of multinational or regional partners and distributors, as well as via AMS's own direct sales forces in the UK, Germany, the Czech Republic and Russia.  Established in 1991, the Company has 600 employees.  For more information, please see www.admedsol.com.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHBSGDSXDBBGRG